0001854863 2021-03-10 2021-12-31 0001854863 bwcau:UnitsEachConsistingOfOneClassOrdinaryShareAndOnefourthOfOneRedeemableWarrantMember 2021-03-10 2021-12-31 0001854863 bwcau:ClassOrdinarySharesParValue0.0001PerShareMember 2021-03-10 2021-12-31 0001854863 bwcau:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member 2021-03-10 2021-12-31 0001854863 2021-06-30 0001854863 bwcau:CommonClassFMember 2022-04-07 0001854863 bwcau:CommonClassGMember 2022-04-07 0001854863 2021-12-31 0001854863 us-gaap:CommonClassAMember 2021-12-31 0001854863 bwcau:CommonClassFMember 2021-12-31 0001854863 bwcau:CommonClassGMember 2021-12-31 0001854863 bwcau:CommonClassFMember 2021-03-09 0001854863 bwcau:CommonClassGMember 2021-03-09 0001854863 us-gaap:AdditionalPaidInCapitalMember 2021-03-09 0001854863 us-gaap:RetainedEarningsMember 2021-03-09 0001854863 2021-03-09 0001854863 bwcau:CommonClassFMember 2021-03-10 2021-12-31 0001854863 bwcau:CommonClassGMember 2021-03-10 2021-12-31 0001854863 us-gaap:AdditionalPaidInCapitalMember 2021-03-10 2021-12-31 0001854863 us-gaap:RetainedEarningsMember 2021-03-10 2021-12-31 0001854863 bwcau:CommonClassFMember 2021-12-31 0001854863 bwcau:CommonClassGMember 2021-12-31 0001854863 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001854863 us-gaap:RetainedEarningsMember 2021-12-31 0001854863 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-08-01 2021-08-06 0001854863 us-gaap:CommonClassAMember 2021-08-01 2021-08-06 0001854863 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-08-06 0001854863 us-gaap:WarrantMember us-gaap:OverAllotmentOptionMember 2021-08-01 2021-08-16 0001854863 bwcau:SponsorMember bwcau:PrivatePlacementWarrantsMember 2021-08-01 2021-08-18 0001854863 bwcau:SponsorMember bwcau:PrivatePlacementWarrantsMember 2021-08-18 0001854863 us-gaap:WarrantMember us-gaap:IPOMember 2021-08-01 2021-08-06 0001854863 us-gaap:WarrantMember us-gaap:IPOMember 2021-08-06 0001854863 2021-08-06 0001854863 2021-08-01 2021-08-06 0001854863 srt:MaximumMember bwcau:ProposedPublicOfferingMember 2021-12-31 0001854863 bwcau:SposorMember us-gaap:CommonClassBMember 2021-03-10 2021-12-31 0001854863 bwcau:SposorMember 2021-12-31 0001854863 us-gaap:SubsequentEventMember 2022-02-22 0001854863 bwcau:DirectorsMember 2021-03-10 2021-12-31 0001854863 bwcau:DirectorsMember 2021-12-31 0001854863 us-gaap:CommonClassAMember 2021-03-10 2021-12-31 0001854863 bwcau:CommonClassFMember 2021-03-10 2021-12-31 0001854863 us-gaap:CommonClassAMember 2021-08-06 0001854863 bwcau:PublicWarrantsMember us-gaap:CommonClassAMember 2021-08-06 0001854863 us-gaap:OverAllotmentOptionMember 2021-08-01 2021-08-16 0001854863 bwcau:PrivatePlacementWarrantsMember 2021-08-01 2021-08-16 0001854863 bwcau:PrivatePlacementWarrantsMember us-gaap:OverAllotmentOptionMember 2021-08-01 2021-08-16 0001854863 bwcau:SponsorMember us-gaap:CommonClassBMember 2021-03-01 2021-03-11 0001854863 us-gaap:CommonClassBMember 2021-12-31 0001854863 bwcau:CommonClassFMember us-gaap:OverAllotmentOptionMember 2021-08-01 2021-08-18 0001854863 bwcau:CommonClassGMember us-gaap:OverAllotmentOptionMember 2021-08-01 2021-08-18 0001854863 bwcau:SponsorMember 2021-03-11 0001854863 bwcau:SponsorMember 2021-12-31 0001854863 bwcau:WorkingCapitalLoansMember 2021-12-31 0001854863 bwcau:AdministrativeServiceFeeMember bwcau:SponsorMember 2021-08-01 2021-08-06 0001854863 us-gaap:OverAllotmentOptionMember bwcau:UnderwritingAgreementMember 2021-03-10 2021-12-31 0001854863 us-gaap:OverAllotmentOptionMember bwcau:UnderwritingAgreementMember 2021-12-31 0001854863 us-gaap:OverAllotmentOptionMember 2021-08-16 0001854863 bwcau:UnderwritingAgreementMember 2021-08-16 0001854863 bwcau:ForwardPurchaseAgreementMember 2021-03-10 2021-12-31 0001854863 bwcau:PublicWarrantsMember us-gaap:CommonClassAMember 2021-03-10 2021-12-31 0001854863 bwcau:CommonClassFMember 2021-03-11 0001854863 bwcau:CommonClassGMember 2021-03-11 0001854863 us-gaap:IPOMember 2021-03-10 2021-12-31 0001854863 bwcau:TriggeringPriceOneMember 2021-12-31 0001854863 bwcau:TriggeringPriceTwoMember 2021-12-31 0001854863 bwcau:TriggeringPriceThreeMember 2021-12-31 0001854863 bwcau:TriggeringPriceOneMember 2021-03-10 2021-12-31 0001854863 bwcau:TriggeringPriceTwoMember 2021-03-10 2021-12-31 0001854863 bwcau:TriggeringPriceThreeMember 2021-03-10 2021-12-31 0001854863 bwcau:PublicWarrantsMember 2021-03-10 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember 2021-03-10 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceOneMember bwcau:WarrantRedemptionPriceOneMember bwcau:PublicWarrantsMember 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceTwoMember bwcau:WarrantRedemptionPriceTwoMember bwcau:PublicWarrantsMember 2021-03-10 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceOneMember bwcau:WarrantRedemptionExercisePricePercentageOneMember bwcau:WarrantRedemptionPriceOneMember bwcau:PublicWarrantsMember 2021-03-10 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceOneMember bwcau:WarrantRedemptionPriceOneMember bwcau:PublicWarrantsMember 2021-03-10 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceTwoMember bwcau:WarrantRedemptionPriceTwoMember bwcau:PublicWarrantsMember 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceOneMember srt:MinimumMember bwcau:PrivateWarrantsMember 2021-12-31 0001854863 bwcau:RedemptionTriggerPriceTwoMember srt:MaximumMember bwcau:PrivateWarrantsMember 2021-12-31 0001854863 bwcau:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember bwcau:PublicWarrantsMember 2021-03-10 2021-12-31 0001854863 bwcau:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember bwcau:PublicWarrantsMember 2021-12-31 0001854863 bwcau:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember bwcau:WarrantRedemptionExercisePricePercentageOneMember bwcau:PublicWarrantsMember 2021-12-31 0001854863 bwcau:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember bwcau:WarrantRedemptionExercisePricePercentageTwoMember bwcau:PublicWarrantsMember 2021-12-31 0001854863 bwcau:PrivateWarrantsMember 2021-03-10 2021-12-31 0001854863 us-gaap:FairValueInputsLevel1Member bwcau:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel2Member bwcau:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel3Member bwcau:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 bwcau:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel1Member bwcau:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel2Member bwcau:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel3Member bwcau:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-03-10 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-03-10 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-03-10 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-03-10 2021-12-31 0001854863 bwcau:PrivatePlacementWarrantsMember 2021-12-31 0001854863 us-gaap:FairValueInputsLevel3Member bwcau:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-08-04 0001854863 us-gaap:FairValueInputsLevel3Member bwcau:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-08-05 2021-12-31 0001854863 bwcau:ForwardPurchaseAgreementAssetMember us-gaap:FairValueInputsLevel3Member 2021-08-04 0001854863 bwcau:ForwardPurchaseAgreementAssetMember us-gaap:FairValueInputsLevel3Member 2021-08-05 2021-12-31 0001854863 bwcau:ForwardPurchaseAgreementAssetMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001854863 bwcau:SponsorMember us-gaap:SubsequentEventMember 2022-02-22 iso4217:USD shares iso4217:USD shares pure 0001854863 false 2021 FY

10-K true 2021-12-31 --12-31 false Blue Whale Acquisition Corp I E9 001-40706 98-1590107 PO Box 1093 Boundary Hall Cricket Square Grand Cayman KY KY1-1102 (345) 949-8066 Units, each consisting of one Class A ordinary share and one-fourth of one redeemable Warrant BWCAU NASDAQ Class A ordinary shares, par value $0.0001 per share BWC NASDAQ Redeemable Warrants, each whole Warrant exercisable for one Class A ordinary share at an exercise price of $11.50 BWCAW NASDAQ No No No Yes Yes Non-accelerated Filer true true false false true 0 2548979 5097958 Marcum LLP Chicago, IL 688

66156

801822

867978

150000

455000

229408110

230881088

966011

156384

325000

1477395

7674891

8029284

17151570

22940811

229408110

0.0001

5000000

0.0001

500000000

0.0001

30000000

2548979

255

0.0001

30000000

5097958

509

-15679356

-15678592

230881088

948902

-984902

385907

-1986443

-250000

865634

11293551 0.06 2373458 0.06 2222222 222 24334 24556 4444445 444 444

3063495

326757 33 653513 65 -98

3087731

16544990

19632721

865634

2548979

255

5097958

509

-15679356

-15678592

865634

-250000

-1986443

385907

1216323

267381

-1933844

229408110

-229408110

224819948

6588162

156384

-156384

231408110

66156

698630 325000 -40500 229408110 8029284 9661333 100000

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Blue Whale Acquisition Corp I (the “Company”) is a blank check company incorporated in the Cayman Islands on March 10, 2021. The Company was formed for the purpose of effectuating a merger, capital share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2021, the Company had not yet commenced any operations. All activity for the period March 10, 2021 (inception) through December 31, 2021, related to the Company’s formation and the initial public offering (the “Initial Public Offering”) and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The registration statement for the Company’s Initial Public Offering was declared effective on August 3, 2021. On August 6, 2021, the Company consummated the Initial Public Offering of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210801__20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDzLggBTuwKi" title="Stock issued during period shares issued in initial public offering">20,000,000 units (“Units” and, with respect to Class A ordinary shares included in the Units offered, the “Public Shares”), generating gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210801__20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4ddHfW12Syi" title="Gross proceeds from issuance of initial public offering">200,000,000, which is described in Note 3. Simultaneously with the initial public offering, the Sponsor purchased an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210801__20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zw72QNfeTte5" title="Stock issued during period shares issued in initial public offering">3,000,000 Private Placement Warrants at a price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFsCB91bPmqe" title="Warrants exercise price per share">2.00 per warrant for an aggregate purchase price of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20210801__20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zxvRjgQeaeoi" title="Gross proceeds from issue of warrants">6,000,000. On August 16, 2021, Goldman Sachs & Co. LLC and BofA Securities (the “underwriters”) partially exercised the over-allotment option granted to it by the Company and purchased an additional <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210801__20210816__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zmam5EKFP6Xc" title="Stock issued during period shares issued for services">2,940,811 Over-Allotment Units, generating an aggregate of gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210801__20210816__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zbIMGMGNuua" title="Proceeds from issuance of common stock">29,408,110, received $<span id="xdx_901_ecustom--UnderwritingFees_pp0p0_c20210801__20210816__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zxrLwSPo0lag" title="Underwriting fees">588,162 in underwriting fees, and forfeited the remainder of the over-allotment option. The over-allotment closed on August 18, 2021. Simultaneously with the closing of the overallotment option, the Company completed the private placement of an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210801__20210818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zITVw0sUOiXe" title="Stock issued during period shares issued in initial public offering">294,081 Private Placement Warrants to the Company’s Sponsor, Blue Whale Sponsor I LLC, at a purchase price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zynqgJLAddn4" title="Warrants exercise price per share">2.00 per Private Warrant, generating gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20210801__20210818__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zpRohJXSGose" title="Gross proceeds from issue of warrants">588,162. Following the closing of the Initial Public Offering on August 6, 2021, an amount of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210801__20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zugqZZF7KZo2">200,000,000 ($<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTzlVkU4SmD3" title="Shares issued price per share">10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering was placed in a Trust Account (as defined below). Transaction costs amounted to $<span id="xdx_909_ecustom--TransactionCostsInConnectionWithInitialPublicOffering_pp0p0_c20210801__20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1znBMtmB8x5" title="Transaction costs">13,781,962 consisting of $<span id="xdx_90F_ecustom--UnderwritingFees_pp0p0_c20210801__20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBLXSJMe5ivj" title="Underwriting fees">4,588,162 of underwriting fees, $<span id="xdx_900_ecustom--DeferredUnderwritingFees_iI_pp0p0_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXafjTbkwttl" title="Deferred underwriting fees">8,029,284 of deferred underwriting fees (see Note 6) and $<span id="xdx_90E_ecustom--OtherCosts_pp0p0_c20210801__20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zM0PmwsoTN1i" title="Other costs">1,164,516 of other costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least <span id="xdx_901_ecustom--ProspectiveAssetsOfAcquireeAsAPercentageOfFairValueOfAssetsInTheTrustAccount_iI_pid_dp_c20210806_zhe0qJQzYfqf" title="Prospective assets of acquiree as a percentage of fair value of assets in the trust account">80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on any interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Initial Public Offering, management has agreed that $10.00 per Unit sold in the Initial Public Offering, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (the “Trust Account”) and may or may not be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that, a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to <span id="xdx_90F_ecustom--PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_iI_pid_dp_c20210806_z88AYTlSFSV9" title="Percentage of public shares to be redeemed in case business combination is not consummated">15% or more of the Public Shares without the Company’s prior written consent. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These shares of Class A ordinary share will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Company’s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5), the ordinary share included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) and Private Placement Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to shareholders’ rights of pre-Business Combination activity and (d) that the Founder Shares and Private Placement Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until August 6, 2023, to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period or during any Extension Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, divided by the number of then outstanding public shares, which redemption will completely extinguish public Shareholder’s rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of applicable law. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit $10.00. The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Placement Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Public Offering price per share ($<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ProposedPublicOfferingMember_zYnVaDV68gfa" title="Shares issued price per share">10.00). In order to protect the amounts held in the trust, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable; provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

20000000

200000000

3000000

2.00

6000000

2940811

29408110

588162

294081

2.00

588162

200000000

10.00

13781962 4588162 8029284 1164516 0.80

0.50

10.00 P185D

5000001

0.15

10.00

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Liquidity and Capital Resources As of December 31, 2021, the Company had approximately $229,408,110 cash held in the Trust Account and $66,156 held outside of the Trust Account. Prior to the completion of the Initial Public Offering, the Company’s liquidity needs has been satisfied through a payment of certain offering costs of $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20210310__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SposorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pp0p0">25,000 from the Sponsor (see Note 5) for the Founder Shares, and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5). As of December 31, 2021, the Company has drawn $156,384 on the Note. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied from the proceeds from the Initial Public Offering and Private Placement not held in the Trust Account. During the period ended December 31, 2021, the Company has sustained negative cash flows from operations and expects to continue to incur negative cash flows from operations for at least the next twelve months from the filing of this report. As of December 31, 2021, these factors raised substantial doubts about the Company’s ability to continue as a going concern. The Company’s Sponsor has undertaken to fund working capital deficiencies of the Company and finance transaction costs in connection with an initial Business Combination of the Company by means of Company working capital loans, as defined below (see Note 5). On February 22, 2022, the Company drew down and received cash proceeds of $2.5 million from the Sponsor under the Working Capital Loan arrangement. Accordingly, management has determined that sufficient capital exists to sustain operations one year from the date of this filing and the substantial doubt about the Company’s ability to continue as a going concern has been alleviated. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $66,156 in cash and no cash equivalents as of December 31, 2021. Cash Held in Trust Account At December 31, 2021, all of the assets held in the Trust Account were held in non-interest bearing cash accounts. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. <p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zH5ghRT1g003" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Shares Subject to Possible Redemption The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of ordinary share (including shares of ordinary share that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. The Company’s shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2021, shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. As of December 31, 2021, the ordinary share reflected on the balance sheet are reconciled in the following table: <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zRw1ggKZURUh" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Scheduled of common stock subject to possible redemption</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210310__20211231_zk1t3ikJ1FH1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Gross Proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">229,408,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ProceedsAllocatedToPublicWarrants_zvAFI2VCBKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,236,666</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--ClassOrdinarySharesIssuanceCosts_zXKnvdo2Kcmc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class A ordinary shares issuance costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,396,055</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccretionExpense_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,632,721</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--ClassOrdinarySharesSubjectToPossibleRedemption_zCGXg6S2falc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">229,408,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $13,781,962 were charged to temporary equity, shareholder’s deficit or operations upon the completion of the Initial Public Offering. Share Based Compensation The transfer of the Founder Shares (see Note 5) is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, share-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon occurrence of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied by the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of December 31, 2021, the Company determined that a Business Combination is not considered probable, and, therefore, no share-based compensation expense has been recognized. The fair value at the grant date of the 125,000 shares transferred to the Company’s directors was $<span id="xdx_901_ecustom--NumberOfShareTransferredValue_c20210310__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsMember_zxb2TxgB2fhf" title="Number of share transferred, Value">222,780 or $ 1.78 per share. Upon consummation of an initial business combination, the Company will recognize $222,780 in compensation expense. Basic income per ordinary share is computed by dividing net income applicable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Consistent with FASB 480, ordinary shares subject to possible redemption, as well as their pro rata share of undistributed trust earnings consistent with the two-class method, have been excluded from the calculation of income per ordinary share for the period from March 10, 2021 (inception) to December 31, 2021. Such shares, if redeemed, only participate in their pro rata share of trust earnings. Diluted income per share includes the incremental number of ordinary shares to be issued to settle warrants, as calculated using the treasury method. For the period from March 10, 2021 (inception) to December 31, 2021, the Company did not have any dilutive warrants, securities or other contracts that could potentially, be exercised or converted into ordinary shares. As a result, diluted income per ordinary share is the same as basic income per ordinary share for all periods presented. A reconciliation of net income per ordinary share is as follows: <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXLflOTHeTY7" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Scheduled of basic and diluted net loss per share</td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20210310__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWpGcBgaTDuc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210310__20211231__us-gaap--StatementClassOfStockAxis__custom--CommonClassFMember_zH35d7gHqi2a" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Period from March 10, 2021 (Date of Inception) through December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class A</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class F</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_ecustom--BasicAndDilutedNetIncomePerShareAbstract_iB_zVcUEjhIcZp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted net income per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--Numerators_i" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AllocationOfNetIncomeAsAdjusted_zBAjhN6DDYmh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">715,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">150,329</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Denominators_i" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BasicAndDilutedWeightedAverageOrdinarySharesOutstanding_zdAcX4XyInKj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted weighted average ordinary shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,293,551</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,373,458</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BasicAndDilutedNetIncomePerOrdinaryShare_zGu0Yda6vHK" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted net income per ordinary share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.06</td><td style="text-align: left"> </td></tr> </table> Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Recently Issued Accounting Standards In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020- 06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its financial statements. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

Liquidity and Capital Resources As of December 31, 2021, the Company had approximately $229,408,110 cash held in the Trust Account and $66,156 held outside of the Trust Account. Prior to the completion of the Initial Public Offering, the Company’s liquidity needs has been satisfied through a payment of certain offering costs of $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20210310__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SposorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pp0p0">25,000 from the Sponsor (see Note 5) for the Founder Shares, and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5). As of December 31, 2021, the Company has drawn $156,384 on the Note. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied from the proceeds from the Initial Public Offering and Private Placement not held in the Trust Account. During the period ended December 31, 2021, the Company has sustained negative cash flows from operations and expects to continue to incur negative cash flows from operations for at least the next twelve months from the filing of this report. As of December 31, 2021, these factors raised substantial doubts about the Company’s ability to continue as a going concern. The Company’s Sponsor has undertaken to fund working capital deficiencies of the Company and finance transaction costs in connection with an initial Business Combination of the Company by means of Company working capital loans, as defined below (see Note 5). On February 22, 2022, the Company drew down and received cash proceeds of $2.5 million from the Sponsor under the Working Capital Loan arrangement. Accordingly, management has determined that sufficient capital exists to sustain operations one year from the date of this filing and the substantial doubt about the Company’s ability to continue as a going concern has been alleviated.

229408110

66156

25000

300000

156384

2500000 Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $66,156 in cash and no cash equivalents as of December 31, 2021.

66156

Cash Held in Trust Account At December 31, 2021, all of the assets held in the Trust Account were held in non-interest bearing cash accounts.

Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

<p id="xdx_84D_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zH5ghRT1g003" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Shares Subject to Possible Redemption The Company accounts for its shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of ordinary share (including shares of ordinary share that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. The Company’s shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2021, shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. As of December 31, 2021, the ordinary share reflected on the balance sheet are reconciled in the following table: <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zRw1ggKZURUh" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Scheduled of common stock subject to possible redemption</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210310__20211231_zk1t3ikJ1FH1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Gross Proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">229,408,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ProceedsAllocatedToPublicWarrants_zvAFI2VCBKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,236,666</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--ClassOrdinarySharesIssuanceCosts_zXKnvdo2Kcmc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class A ordinary shares issuance costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,396,055</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccretionExpense_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,632,721</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--ClassOrdinarySharesSubjectToPossibleRedemption_zCGXg6S2falc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">229,408,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zRw1ggKZURUh" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Scheduled of common stock subject to possible redemption</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210310__20211231_zk1t3ikJ1FH1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Gross Proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">229,408,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ProceedsAllocatedToPublicWarrants_zvAFI2VCBKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,236,666</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--ClassOrdinarySharesIssuanceCosts_zXKnvdo2Kcmc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class A ordinary shares issuance costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,396,055</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccretionExpense_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,632,721</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--ClassOrdinarySharesSubjectToPossibleRedemption_zCGXg6S2falc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">229,408,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

229408110

-6236666 -13396055

19632721

229408110 Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $13,781,962 were charged to temporary equity, shareholder’s deficit or operations upon the completion of the Initial Public Offering.

13781962

Share Based Compensation The transfer of the Founder Shares (see Note 5) is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, share-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon occurrence of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied by the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of December 31, 2021, the Company determined that a Business Combination is not considered probable, and, therefore, no share-based compensation expense has been recognized. The fair value at the grant date of the 125,000 shares transferred to the Company’s directors was $<span id="xdx_901_ecustom--NumberOfShareTransferredValue_c20210310__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsMember_zxb2TxgB2fhf" title="Number of share transferred, Value">222,780 or $ 1.78 per share. Upon consummation of an initial business combination, the Company will recognize $222,780 in compensation expense. Basic income per ordinary share is computed by dividing net income applicable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Consistent with FASB 480, ordinary shares subject to possible redemption, as well as their pro rata share of undistributed trust earnings consistent with the two-class method, have been excluded from the calculation of income per ordinary share for the period from March 10, 2021 (inception) to December 31, 2021. Such shares, if redeemed, only participate in their pro rata share of trust earnings. Diluted income per share includes the incremental number of ordinary shares to be issued to settle warrants, as calculated using the treasury method. For the period from March 10, 2021 (inception) to December 31, 2021, the Company did not have any dilutive warrants, securities or other contracts that could potentially, be exercised or converted into ordinary shares. As a result, diluted income per ordinary share is the same as basic income per ordinary share for all periods presented. A reconciliation of net income per ordinary share is as follows: <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXLflOTHeTY7" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Scheduled of basic and diluted net loss per share</td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20210310__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWpGcBgaTDuc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210310__20211231__us-gaap--StatementClassOfStockAxis__custom--CommonClassFMember_zH35d7gHqi2a" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Period from March 10, 2021 (Date of Inception) through December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class A</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class F</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_ecustom--BasicAndDilutedNetIncomePerShareAbstract_iB_zVcUEjhIcZp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted net income per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--Numerators_i" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AllocationOfNetIncomeAsAdjusted_zBAjhN6DDYmh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">715,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">150,329</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Denominators_i" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BasicAndDilutedWeightedAverageOrdinarySharesOutstanding_zdAcX4XyInKj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted weighted average ordinary shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,293,551</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,373,458</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BasicAndDilutedNetIncomePerOrdinaryShare_zGu0Yda6vHK" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted net income per ordinary share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.06</td><td style="text-align: left"> </td></tr> </table> 125000 222780

1.78

222780

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXLflOTHeTY7" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Scheduled of basic and diluted net loss per share</td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20210310__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWpGcBgaTDuc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210310__20211231__us-gaap--StatementClassOfStockAxis__custom--CommonClassFMember_zH35d7gHqi2a" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Period from March 10, 2021 (Date of Inception) through December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class A</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class F</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_ecustom--BasicAndDilutedNetIncomePerShareAbstract_iB_zVcUEjhIcZp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted net income per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--Numerators_i" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AllocationOfNetIncomeAsAdjusted_zBAjhN6DDYmh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">715,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">150,329</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Denominators_i" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BasicAndDilutedWeightedAverageOrdinarySharesOutstanding_zdAcX4XyInKj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted weighted average ordinary shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,293,551</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,373,458</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BasicAndDilutedNetIncomePerOrdinaryShare_zGu0Yda6vHK" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Basic and diluted net income per ordinary share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.06</td><td style="text-align: left"> </td></tr> </table>

715305 150329 11293551 2373458 0.06 0.06

Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recently Issued Accounting Standards In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020- 06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its financial statements. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210801__20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEa4cbCPaSJk" title="Stock shares issued during the period shares new issues">20,000,000 Units at a purchase price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pp2d_c20210806__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrA9276BTV3c" title="Shares issued, price per share">10.00 per Unit. Each Unit will consist of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210806__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zSQxWEc5KGpk" title="Class of warrant or right, exercise price of warrants or rights">11.50 per whole share (see Note 9). On August 16, 2021, the underwriters partially exercised the over-allotment option and purchased an additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210801__20210816__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z9XWCN7A2f1k" title="Stock shares issued during the period shares new issues">2,940,811 Over-Allotment Units, generating an aggregate of gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210801__20210816__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ziGuGYj5qA38" title="Proceeds from issuance of common stock">29,408,110, received $588,162 in underwriting fees in cash, and forfeited the remainder of the over-allotment option. The over-allotment closed on August 18, 2021.

20000000

10.00

0.0001

11.50

2940811

29408110

58816200 NOTE 4. PRIVATE PLACEMENT Simultaneously with the initial public offering, the Sponsor purchased an aggregate of <span id="xdx_906_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_pid_c20210801__20210816__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z74uvquO7115" title="Class of warrants and rights issued during the period">3,000,000 Private Placement Warrants at a price of $<span id="xdx_90E_ecustom--ClassOfWarrantsAndRightsIssuedPricePerWarrant_pid_c20210801__20210816__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zJFqAPD6zepa" title="Class of warrants and rights issued, price per warrant">2.00 per warrant for an aggregate purchase price of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20210801__20210816__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDc05TULKKz1" title="Gross proceeds from private placement issue">6,000,000. Simultaneously with the closing of the overallotment option, the Company completed the private sale of an additional <span id="xdx_90B_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_pid_c20210801__20210816__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zITxq7GKyE7i" title="Class of warrants and rights issued during the period">294,081 Private Placement Warrants to the Company’s Sponsor, Blue Whale Sponsor I LLC, at a purchase price of $<span id="xdx_90B_ecustom--ClassOfWarrantsAndRightsIssuedPricePerWarrant_pid_c20210801__20210816__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zg3J6oN0exLi" title="Class of warrants and rights issued, price per warrant">2.00 per Private Warrant, generating gross proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20210801__20210816__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGElaR0eLme8" title="Gross proceeds from private placement issue">588,162. Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the Trust Account with respect to Private Placement Warrants, which will expire worthless if we do not consummate a Business Combination within the Combination Period. 3000000 2.00

6000000

294081 2.00

588162

NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On March 11, 2021, the Company issued an aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210311__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zrMxDpB73HT7" title="Stock issued during period shares issued for services">5,750,000 shares of Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20210301__20210311__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zGBEqa8lsN11" title="Stock issued during period, value, issued for services">25,000. The Founder Shares include an aggregate of up to 750,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part. Such shares have been recapitalized into 2,548,979 Class F ordinary shares and 5,097,958 Class G ordinary shares (which we respectively refer to as “Class F founder shares” and “Class G founder shares,” and collectively refer to as “founder shares” as further described herein). Pursuant to a re-organization of the Company’s share capital effective July 5, 2021, the Class B ordinary shares have been canceled and all of the shares presently issued and outstanding are Class F ordinary shares and Class G ordinary shares. (See Note 8). On August 18, 2021, the underwriters partially exercised the over-allotment option resulting in the issuance of an additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210801__20210818__us-gaap--StatementClassOfStockAxis__custom--CommonClassFMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z2oLPZGLP8yi" title="Stock issued during period shares issued for services">326,757 Class F ordinary shares and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210801__20210818__us-gaap--StatementClassOfStockAxis__custom--CommonClassGMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjJOZGHNC6pi" title="Stock issued during period shares issued for services">653,513 Class G ordinary shares to the Sponsor. On September 17, 2021, the remaining balance of the over-allotment option expired unexercised and was therefore forfeited. The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until two years after the completion of a Business Combination. Promissory Note — Related Party On March 11, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note is non-interest bearing and is payable on the earlier of (i) December 31, 2022 or (ii) the date the Company completes its initial Business Combination. As of December 31, 2021, the Company has drawn $156,384 on the Note which is classified as current on our Balance Sheet. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. On February 16, 2022, the Sponsor confirmed to the Company that it will provide any such Working Capital Loans for at least the next twelve months, pursuant to a promissory note. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c20211231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pp0p0" title="Debt instrument, convertible, warrants issued">2,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20211231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_zhcEYirbF6Tb" title="Warrants issued price per warrant">2.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. In addition, our Sponsor, officers and directors, or our respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our Sponsor, executive officers or directors, or our affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account. There was $325,000 due to related party at December 31, 2021. Administrative Support Agreement The Company entered into an agreement, whereby, commencing on August 6, 2021, through the earlier of the consummation of a Business Combination or the Company’s liquidation, the Company may reimburse an affiliate of the Sponsor up to an amount of $<span id="xdx_903_ecustom--RelatedPartyTransactionReimburseOfExpensesFromTransactionsWithRelatedParty_pp0p0_c20210801__20210806__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServiceFeeMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zh4P24Ra8Cyd" title="Reimburse of expenses from transactions with related party">10,000 per month for office space and secretarial and administrative support.

5750000

25000

750000

2548979

5097958

326757

653513

300000

156384

2500000

2.00

325000

10000

NOTE 6. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants, the Forward Purchase Warrant, the Units, and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement Pursuant to the Underwriting Agreement, the underwriters were paid a cash underwriting discount of <span id="xdx_90F_ecustom--CashUnderwritingDiscountPercent_pid_dp_c20210310__20211231__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFhCnJclBBtd" title="Cash underwriting discount percent">2.00% of the gross proceeds of the Initial Public Offering, or $<span id="xdx_909_ecustom--PaymentOfUnderwritingDiscount_pp0p0_c20210310__20211231__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpu3ivYY5a4g" title="Payment of underwriting discount">4,488,162. In addition, the underwriters will be entitled to a deferred fee of three and half percent (<span id="xdx_907_ecustom--DeferredUnderwritingFeePercent_pid_dp_c20210310__20211231__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ztStBiZ6LBk8" title="Deferred underwriting fee percent">3.50%) of the gross proceeds of the Initial Public Offering, or $<span id="xdx_90D_eus-gaap--DeferredCompensationLiabilityClassifiedNoncurrent_iI_pp0p0_c20211231__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zKxVUDJIj0N" title="Deferred compensation liability, classified, noncurrent">8,029,284. On August 16, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210801__20210816__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zkD3FvF82PAh" title="Stock issued during period shares issued in initial public offering">2,940,811 Over-Allotment Units, generating an aggregate of gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210801__20210816__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znqwdIRrZI86" title="Proceeds from issuance of common stock">29,408,110, incurred $588,162 in cash underwriting fees and $1,029,284 in deferred underwriters’ fees, and forfeited the remainder of the option, which over-allotment closed on August 18, 2021. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreement The Company entered into a Forward Purchase Agreement (“FPA”) that will provide for the purchase of an aggregate of <span id="xdx_90C_ecustom--ClassOfWarrantsAndRightsIssuedDuringThePeriod_pid_c20210310__20211231__us-gaap--TransactionTypeAxis__custom--ForwardPurchaseAgreementMember_z20fllseGGG1" title="Class of warrants and rights issued during the period">5,000,000 units for an aggregate purchase price of up to $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20210310__20211231__us-gaap--TransactionTypeAxis__custom--ForwardPurchaseAgreementMember_zM3DU26KSkMl" title="Gross proceeds from private placement issue">50,000,000, or $<span id="xdx_909_ecustom--ClassOfWarrantsAndRightsIssuedPricePerWarrant_pid_c20210310__20211231__us-gaap--TransactionTypeAxis__custom--ForwardPurchaseAgreementMember_zOMzsfpBGeFf" title="Class of warrants and rights issued, price per warrant">10.00 per unit, in a private placement to close substantially concurrently with the closing of our initial business combination. The forward purchase investor will determine in its sole discretion the specific number of forward purchase units it will purchase, if any, pursuant to the forward purchase agreement. <span id="xdx_90B_eus-gaap--CommonStockConversionBasis_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember" title="Stock Conversion Basis">Each forward purchase unit will consist of one Class A ordinary share and one- fourth of one redeemable warrant. The terms of the forward purchase units will generally be identical to the terms of the units being issued in this offering, except that the securities underlying the forward purchase units will be subject to certain registration rights. Consistent with the warrant liability discussed in Note 9, the Company will account for the FPA in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the FPA units do not meet the criteria for equity treatment thereunder, each unit must be recorded as an asset or a liability. The Company will classify the FPA at its fair value. The FPA is subject to re-measurement at each balance sheet date. With each such remeasurement, the FPA will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.

0.0200 4488162 0.0350

8029284

2940811

29408110

588162 1029284 5000000

50000000

10.00

Each forward purchase unit will consist of one Class A ordinary share and one- fourth of one redeemable warrant.

NOTE 7. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2021, there were 22,940,811 Class A ordinary shares outstanding which were subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.

500000000

0.0001

one

22940811

NOTE 8. SHAREHOLDER’S EQUITY Preferred Shares — The Company is authorized to issue 5,000,000 shares of $0.0001 par value preferred share. At December 31, 2021, there were no preferred share issued or outstanding. Founder shares — The Company is authorized to issue up to 30,000,000 class F ordinary shares, $0.0001 par value and 30,000,000 class G ordinary shares, $0.0001 par value, out of which we have issued 2,548,979 Class F ordinary shares and 5,097,958 Class G ordinary shares. Holders of the Company’s ordinary shares are entitled to one vote for each share. At December 31, 2021, there were 2,548,979 and 5,097,958 Class F and Class G ordinary shares issued and outstanding, respectively. (See Note 5) Shareholders of record are entitled to one vote for each share held (on an as-converted to Class A ordinary share basis) on all matters to be voted on by shareholders. Prior to our initial Business Combination, only holders of our Class F ordinary shares will have the right to vote on the appointment of directors. Holders of our Class G ordinary shares and public shares will not be entitled to vote on the appointment of directors during such time. The Class F founder shares will automatically convert into Class A ordinary shares on the first business day following the closing of our initial business combination, at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class F founder shares will equal, in the aggregate on an as converted basis, <span id="xdx_903_ecustom--PercentageOfNumberOfSharesOfCommonStockOutstanding_pid_c20210310__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zchnzfeTWrzd" title="Percentage of number of shares of common stock outstanding">10% of the sum of (i) the total number of all Class A ordinary shares issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their over-allotment option and without giving effect to any redemptions of any public shares in connection with the initial business combination), plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion of the Class F founder shares, plus (iii) unless waived by our Sponsor, the total number of Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, in connection with or in relation to the consummation of the initial business combination, including any forward purchase shares, and excluding (x) any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial business combination and (y) any Class A ordinary shares issuable upon conversion of the Class G founder shares. Prior to our initial business combination, only holders of our Class F ordinary shares will be entitled to vote on the appointment of directors. The Class G founder shares will convert into Class A ordinary shares after our initial business combination only to the extent certain triggering events occur prior to the applicable anniversary of our initial business combination including three triggering events based on our shares trading at $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20211231__custom--TriggeringEventPriceAxis__custom--TriggeringPriceOneMember_pp2d" title="Debt instrument, convertible, conversion price">15.00, $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20211231__custom--TriggeringEventPriceAxis__custom--TriggeringPriceTwoMember_pp2d" title="Debt instrument, convertible, conversion price">20.00 and $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20211231__custom--TriggeringEventPriceAxis__custom--TriggeringPriceThreeMember_pp2d" title="Debt instrument, convertible, conversion price">25.00 per share following the closing of our initial business combination and also upon specified strategic transactions, in each case, as described in the Company’s final prospectus filed with the SEC on August 4, 2021 (the “Prospectus”). The Class G founder shares will be convertible into Class A ordinary shares at a ratio such that the number of Class A ordinary shares issuable upon conversion of all founder shares (including both Class F founder shares and Class G founder shares) would equal, in the aggregate on an as-converted basis, <span id="xdx_902_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_c20210310__20211231__custom--TriggeringEventPriceAxis__custom--TriggeringPriceOneMember_ziNTrtuPbjsd" title="Debt instrument, convertible, threshold percentage of stock price trigger">15%, <span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_c20210310__20211231__custom--TriggeringEventPriceAxis__custom--TriggeringPriceTwoMember_zNWL4db1IeMe" title="Debt instrument, convertible, threshold percentage of stock price trigger">20% and <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_c20210310__20211231__custom--TriggeringEventPriceAxis__custom--TriggeringPriceThreeMember_zpTar7cXzsNh" title="Debt instrument, convertible, threshold percentage of stock price trigger">25% (based on varying triggers as discussed in more detail in the Prospectus) of the sum of (i) the total number of all Class A ordinary shares issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their over-allotment option and without giving effect to any redemptions of any public shares in connection with the initial business combination), plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion of the Class F founder shares and Class G founder shares, plus (iii) unless waived by our Sponsor, the total number of Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, in connection with or in relation to the consummation of the initial business combination, including any forward purchase shares and excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial business combination. The Class G ordinary shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination), as well as various market conditions (i.e., share price targets after consummation of the Business Combination). The various market conditions are considered in determining the grant date fair value of these instruments using Monte Carlo simulation. Compensation expense related to the Class G ordinary shares is recognized only when the performance condition is probable of occurrence.

5000000

0.0001

30000000

0.0001

30000000

0.0001

2548979

5097958

2548979

5097958

15.00

20.00

25.00

0.15

0.20

0.25

NOTE 9. WARRANT LIABILITIES The Company accounts for 9,029,283 warrants—<span id="xdx_90C_ecustom--ClassOfWarrantsOrRightsIssuedDuringThePeriod_pid_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTXK6VXi7ps5" title="Class of warrants or rights issued during the period">5,735,202 Public Warrants and the <span id="xdx_908_ecustom--ClassOfWarrantsOrRightsIssuedDuringThePeriod_pid_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zAMLboHBg3x7" title="Class of warrants or rights issued during the period">3,294,081 Private Placement Warrants—issued in connection with the Proposed Public Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable <span id="xdx_90B_ecustom--ClassOfWarrantsOrRightsPeriodAfterWhichTheyAreExercisableFromTheConsummationOfBusinessCombination_dtD_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zj4bTtWyy7Kf" title="Class of warrants or rights period after which they are excercisable from the consummation of business combination">30 days after the consummation of a Business Combination. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than <span id="xdx_90E_ecustom--ClassOfWarrantsOrRightsPeriodWithinWhichTheyMustBeRegisteredFromTheConsummationOfBusinessCombination_dtD_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zr7r0TVlsiab" title="Class of warrants or rights period within which they must be registered from the consummation of business combination">15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A ordinary shares issuable upon exercise of the warrants is not effective by the <span id="xdx_90E_ecustom--ClassOfWarrantsOrRightsPeriodWithinWhichTheRegistrationShallBeEffectiveFromTheConsummationOfBusinessCombination_dtD_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zILFi5zhpxu8" title="Class of warrants or rights period within the registration shall be effective from the consummation of business combination">60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Redemption of warrants when the price per Class A ordinary share equals or exceeds $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceOneMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceOneMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAhmbQrn1yT3" title="Share price">18.00. Once the warrants become exercisable, the Company may redeem the Warrants for redemption: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">in whole and not in part;</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">at a price of $<span id="xdx_90E_ecustom--ClassOfWarrantsOrRightsRedemptionPricePerShare_iI_pid_c20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceOneMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceOneMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ztvZzo90Bgyj" title="Class of warrants or rights redemption price per share">0.01 per Public Warrant;</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">upon not less than <span id="xdx_90E_ecustom--MinimumNoticePeriodToBeGivenToWarrantHoldersPriorToRedemption_dtD_c20210310__20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceTwoMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceTwoMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zutxejlP0WOf" title="Minimum notice period to be given to warrant holders prior to redemption">30 days’ prior written notice of redemption to each warrant holder and</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described) for any <span id="xdx_901_ecustom--NumberOfTradingDaysForDeterminingTheSharePrice_dtD_c20210310__20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceOneMember__custom--WarrantRedemptionExercisePricePercentageAxis__custom--WarrantRedemptionExercisePricePercentageOneMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceOneMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUE6P7ZCObt" title="Number of trading days for determining the share price">20 trading days within a <span id="xdx_90B_ecustom--NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_dtD_c20210310__20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceOneMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceOneMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAj8fWoqKLa6" title="Number of consecutive trading days for determining the share price">30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.</td> </tr></table> The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by us, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $<span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceTwoMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceTwoMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUAhNx1wr7f6" title="Share price">10.00. Once the Warrants become exercisable, the Company may redeem the Warrants for redemption: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">in whole and not in part;</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">at $<span id="xdx_901_ecustom--ClassOfWarrantsOrRightsRedemptionPricePerShare_iI_pid_c20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceTwoMember__custom--WarrantRedemptionPriceAxis__custom--WarrantRedemptionPriceTwoMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_znHAdhQsCYn3" title="Class of warrants or rights redemption price per share">0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table based on the redemption date and the “fair market value” of our Class A ordinary shares;</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">if, and only if, the Reference Value (as defined above under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00”) equals or exceeds $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceOneMember__srt--RangeAxis__srt--MinimumMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_zfLDATkY79Xj" title="Share price">10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant); and</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">if the Reference Value is less than $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20211231__custom--SharePriceTriggeringRedemptionOfWarrantsAxis__custom--RedemptionTriggerPriceTwoMember__srt--RangeAxis__srt--MaximumMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_zmzvSxBeSTK5" title="Share price">18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the private placement warrants must also concurrently be called for redemption on the same terms as the outstanding public warrants, as described above.</td> </tr></table> If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of ordinary shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The exercise price and number of shares of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues, other than in connection with its forward purchase agreement, additional ordinary shares or equity- linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $<span id="xdx_900_ecustom--VolumeWeightedAveragePricePerShare_pid_c20210310__20211231__custom--EventAxis__custom--EventTriggeringAdjustmentToExercisePriceOfWarrantsMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zdzh2ViKytj" title="Volume weighted average price per share">9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than <span id="xdx_902_ecustom--PercentageOfFundsRaisedToBeUsedForConsummatingBusinessCombination_pid_dp_c20210310__20211231__custom--EventAxis__custom--EventTriggeringAdjustmentToExercisePriceOfWarrantsMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zJaD4oFCWaT3" title="Percentage of funds raised to be used for consummating business combination">60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the <span id="xdx_90C_ecustom--NumberOfTradingDaysForDeterminingTheVolumeWeightedAveragePriceOfShare_dtD_c20210310__20211231__custom--EventAxis__custom--EventTriggeringAdjustmentToExercisePriceOfWarrantsMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zytLGmVyrzM7" title="Number of consecutive trading days for determining the volume weighted average price of share">20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20211231__custom--EventAxis__custom--EventTriggeringAdjustmentToExercisePriceOfWarrantsMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaAMZoaQ1Nzh" title="Shares issued price per share">9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <span id="xdx_90D_ecustom--ClassOfWarrantsOrRightsExercisePricePercentage_iI_pid_dp_c20211231__custom--EventAxis__custom--EventTriggeringAdjustmentToExercisePriceOfWarrantsMember__custom--WarrantRedemptionExercisePricePercentageAxis__custom--WarrantRedemptionExercisePricePercentageOneMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcpeclyPEOYi" title="Class of warrants or rights exercise price percentage">115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to <span id="xdx_90E_ecustom--ClassOfWarrantsOrRightsExercisePricePercentage_iI_pid_dp_c20211231__custom--EventAxis__custom--EventTriggeringAdjustmentToExercisePriceOfWarrantsMember__custom--WarrantRedemptionExercisePricePercentageAxis__custom--WarrantRedemptionExercisePricePercentageTwoMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zkR6iOF7Je9" title="Class of warrants or rights exercise price percentage">180% of the greater of the Market Value and the Newly Issued Price. The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Initial Public Offering, except that the Private Placement Warrants will and the shares of ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until <span id="xdx_906_ecustom--ClassOfWarrantsOrRightsLockInPeriod_dtD_c20210310__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_z2HzAYcO3dIa" title="Class of warrants or rights lock in period">30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. 9029283 5735202 3294081 P30D P15D P60D

18.00

0.01 P30D P20D P30D

10.00

0.10

10.00

18.00

9.20 0.60 P20D

9.20

1.15 1.80 P30D

NOTE 10. FAIR VALUE MEASUREMENTS Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</td></tr> </table> The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRXShIGAr6Pa" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Schedule Of Fair Value Hierarchy For Assets and Liabilities Measured At Fair Value on a Recurring basis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Level 1</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Level 2</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Level 3</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Total</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Liabilities: </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Warrant Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%; text-align: left">Public Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHuz36HBfu8e" style="width: 9%; text-align: right" title="Total Warrant Liabilities">4,874,922</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilities_iI_pdp0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDmzQZhdkTt8" style="width: 9%; text-align: right" title="Total Warrant Liabilities">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvlTehfXAt0h" style="width: 9%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zTz6JCwQnKl2" style="width: 9%; text-align: right" title="Total Warrant Liabilities">4,874,922</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Private Placement Warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUXUFb40pQtl" style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zS6eHI6w7XUg" style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWyyXYcvCbTc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Warrant Liabilities">2,799,969</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsf47B2CFcW6" style="border-bottom: Black 1pt solid; text-align: right" title="Total Warrant Liabilities">2,799,969</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Total Warrant Liabilities:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxjmycwRSh2" style="border-bottom: Black 2.5pt double; text-align: right">4,874,922</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iI_pdp0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmV3Cb7NNWMa" style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zf9PH2xTBO81" style="border-bottom: Black 2.5pt double; text-align: right">2,799,969</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKI9f9Uw5Be2" style="border-bottom: Black 2.5pt double; text-align: right">7,674,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">FPA</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzkJMoTnaOPc" style="border-bottom: Black 2.5pt double; text-align: right" title="FPA asset">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zBkLa2H9N3Qg" style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zhuM6puhZm4i" style="border-bottom: Black 2.5pt double; text-align: right" title="FPA asset">150,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeAssets_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="FPA asset">150,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Warrants liabilities and FPA were accounted for in accordance with ASC 815-40 and are presented within warrant liabilities and FPA on our balance sheet. The warrant liabilities and FPA are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities and change in fair value of FPA, respectively, in the statement of operations. Level 1 instruments include the Public Warrants. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The Public Warrants for periods where no observable traded price was available are valued using a barrier option simulation. For the period ended December 31, 2021 (the periods subsequent to the detachment of the Public Warrants from the Units), the Public Warrant quoted market price was used as the fair value as of each relevant date. Initial Measurement Warrants The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations. The Private Warrants were valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z2adS4EZ68V" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Schedule Of Fair Value Of Assets and Liabilities Valuation Techniques and Measurement Inputs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; font-weight: bold; text-align: left">Input</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">Risk-free interest rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90E_ecustom--DerivativeLiabilityMeasurementInputs_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zg3qT68zK4ld" title="Derivative Liability, Measurement Input">1.25</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--DerivativeLiabilityMeasurementInputs_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1jS6ElcfH9f" title="Derivative Liability, Measurement Input">5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--DerivativeLiabilityMeasurementInputs_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zPwN7qiLHm2f" title="Derivative Liability, Measurement Input">14.8</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Exercise Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_ecustom--DerivativeLiabilityMeasurementInputs_pp2d_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zRZStXbcKIqc" title="Derivative Liability, Measurement Input">11.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Share price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_ecustom--DerivativeLiabilityMeasurementInputFairValueOfCommonStock_iI_pp2d_c20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember_zaZWGYTSjtCa" title="Derivative Liability Measurement Input Fair Value Of Common Stock">11.50</td><td style="text-align: left"> </td></tr> </table> The following table presents a summary of the changes in the fair value of the Private Placement Warrants, a Level 3 liability, measured on a recurring basis. <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zaC2K8iksvd1" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Summary Of the changes in the fair value of the warrants measured on recurring basis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">Fair Value as of August 6, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iS_pp0p0_c20210805__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgzi17kxHGHc" style="width: 9%; text-align: right" title="Fair value, Beginning Balance">3,524,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F4C_zkykEJlPZoUe" style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Change in valuation inputs or other assumptions(1)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_iN_pp0p0_di_c20210805__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2f70jv5Ngc" style="text-align: right" title="Change in valuation inputs or other assumptions">(724,698</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Fair Value as of December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iE_c20210805__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zizTe9KcsPHl" style="text-align: right" title="Fair value, Ending Balance">2,799,969</td><td style="text-align: left"> </td></tr> </table> <div style="margin-top: 0; margin-bottom: 0; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in">(1)</td><td style="text-align: justify">Represents the non-cash gain on the change in valuation of the Private Placement Warrants and is included in Gain on change in fair value of warrant liability in the condensed statement of operations.</td></tr></table> FPA The FPA were valued using a discounted cash flows method, which is considered to be a Level 3 fair value measurement. Under the discounted cash flow method utilized, the aggregate commitment of $200 million pursuant to the FPA is discounted to present value and compared to the fair value of the ordinary shares and warrants to be issued pursuant to the FPA. The fair value of the ordinary shares and warrants to be issued under the FPA are based on the public trading price of the Units issued in the Company’s IPO. The excess (liability) or deficit (asset) of the fair value of the ordinary shares and warrants to be issued compared to the $50 million fixed commitment is then reduced to account for the probability of consummation of the Business Combination. The primary unobservable input utilized in determining the fair value of the FPA is the probability of consummation of the Business Combination. As of December 31, 2021, the probability assigned to the consummation of the Business Combination was 95% which was determined based on observed success rates of business combinations for special purpose acquisition companies. <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zSZSTUaZvDV7" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Summary Of the changes in the fair value of the FPA Asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Fair Value as of August 6, 2021 – Liability</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210805__20211231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseAgreementAssetMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeGzR1bN6vAa" style="width: 9%; text-align: right" title="Fair value, Beginning Balance">100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zq08ZHb57Kne" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in valuation inputs or other assumptions(1)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_pp0p0_c20210805__20211231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseAgreementAssetMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zO8bcVhs5cgc" style="text-align: right" title="Change in valuation inputs or other assumptions">(250,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair Value as of December 31, 2021 – (Asset)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pp0p0_c20210805__20211231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseAgreementAssetMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z05soYwrqnpi" style="text-align: right" title="Fair value, Ending Balance">(150,000</td><td style="text-align: left">)</td></tr> </table> <div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in">(1)</td><td style="text-align: justify">Represents the non-cash gain on the change in valuation of the FPA asset and is included in Gain on change in fair value of FPA in the statement of operations.</td></tr></table>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRXShIGAr6Pa" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Schedule Of Fair Value Hierarchy For Assets and Liabilities Measured At Fair Value on a Recurring basis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Level 1</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Level 2</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Level 3</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Total</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Liabilities: </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Warrant Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%; text-align: left">Public Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHuz36HBfu8e" style="width: 9%; text-align: right" title="Total Warrant Liabilities">4,874,922</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilities_iI_pdp0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDmzQZhdkTt8" style="width: 9%; text-align: right" title="Total Warrant Liabilities">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvlTehfXAt0h" style="width: 9%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PublicWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zTz6JCwQnKl2" style="width: 9%; text-align: right" title="Total Warrant Liabilities">4,874,922</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Private Placement Warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUXUFb40pQtl" style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zS6eHI6w7XUg" style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWyyXYcvCbTc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Warrant Liabilities">2,799,969</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsf47B2CFcW6" style="border-bottom: Black 1pt solid; text-align: right" title="Total Warrant Liabilities">2,799,969</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Total Warrant Liabilities:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxjmycwRSh2" style="border-bottom: Black 2.5pt double; text-align: right">4,874,922</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iI_pdp0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmV3Cb7NNWMa" style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zf9PH2xTBO81" style="border-bottom: Black 2.5pt double; text-align: right">2,799,969</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKI9f9Uw5Be2" style="border-bottom: Black 2.5pt double; text-align: right">7,674,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">FPA</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzkJMoTnaOPc" style="border-bottom: Black 2.5pt double; text-align: right" title="FPA asset">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zBkLa2H9N3Qg" style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zhuM6puhZm4i" style="border-bottom: Black 2.5pt double; text-align: right" title="FPA asset">150,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeAssets_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="FPA asset">150,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

4874922

2799969

4874922

2799969

7674891

150000

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z2adS4EZ68V" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Schedule Of Fair Value Of Assets and Liabilities Valuation Techniques and Measurement Inputs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; font-weight: bold; text-align: left">Input</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">Risk-free interest rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90E_ecustom--DerivativeLiabilityMeasurementInputs_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zg3qT68zK4ld" title="Derivative Liability, Measurement Input">1.25</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--DerivativeLiabilityMeasurementInputs_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1jS6ElcfH9f" title="Derivative Liability, Measurement Input">5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--DerivativeLiabilityMeasurementInputs_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zPwN7qiLHm2f" title="Derivative Liability, Measurement Input">14.8</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Exercise Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_ecustom--DerivativeLiabilityMeasurementInputs_pp2d_c20210310__20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zRZStXbcKIqc" title="Derivative Liability, Measurement Input">11.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Share price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_ecustom--DerivativeLiabilityMeasurementInputFairValueOfCommonStock_iI_pp2d_c20211231__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember_zaZWGYTSjtCa" title="Derivative Liability Measurement Input Fair Value Of Common Stock">11.50</td><td style="text-align: left"> </td></tr> </table>

1.25 5 14.8 11.50 11.50

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zaC2K8iksvd1" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Summary Of the changes in the fair value of the warrants measured on recurring basis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">Fair Value as of August 6, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iS_pp0p0_c20210805__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgzi17kxHGHc" style="width: 9%; text-align: right" title="Fair value, Beginning Balance">3,524,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F4C_zkykEJlPZoUe" style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Change in valuation inputs or other assumptions(1)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_iN_pp0p0_di_c20210805__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2f70jv5Ngc" style="text-align: right" title="Change in valuation inputs or other assumptions">(724,698</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Fair Value as of December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iE_c20210805__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zizTe9KcsPHl" style="text-align: right" title="Fair value, Ending Balance">2,799,969</td><td style="text-align: left"> </td></tr> </table> <div style="margin-top: 0; margin-bottom: 0; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in">(1)</td><td style="text-align: justify">Represents the non-cash gain on the change in valuation of the Private Placement Warrants and is included in Gain on change in fair value of warrant liability in the condensed statement of operations.</td></tr></table>

3524667

724698

2799969

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zSZSTUaZvDV7" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Summary Of the changes in the fair value of the FPA Asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Fair Value as of August 6, 2021 – Liability</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210805__20211231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseAgreementAssetMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeGzR1bN6vAa" style="width: 9%; text-align: right" title="Fair value, Beginning Balance">100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zq08ZHb57Kne" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in valuation inputs or other assumptions(1)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_pp0p0_c20210805__20211231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseAgreementAssetMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zO8bcVhs5cgc" style="text-align: right" title="Change in valuation inputs or other assumptions">(250,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair Value as of December 31, 2021 – (Asset)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pp0p0_c20210805__20211231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseAgreementAssetMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z05soYwrqnpi" style="text-align: right" title="Fair value, Ending Balance">(150,000</td><td style="text-align: left">)</td></tr> </table> <div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in">(1)</td><td style="text-align: justify">Represents the non-cash gain on the change in valuation of the FPA asset and is included in Gain on change in fair value of FPA in the statement of operations.</td></tr></table>

100000

-250000

-150000

NOTE 11. SUBSEQUENT EVENTS Management of the Company evaluated events that have occurred after the balance sheet date of December 31, 2021 through the date these financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. On February 22, 2022, pursuant to a promissory note between the Sponsor and the Company signed on February 16, 2022, the Company drew $<span id="xdx_90E_ecustom--WorkingCapitalLoan_iI_c20220222__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_znLG4urm1j9a" title="Working Capital Loan">2,500,000 on the Working Capital Loan with the Sponsor. The Working Capital Loan is non-interest bearing and due on the earlier of the date by which the Company has to complete a Business Combination, and the effective date of a Business Combination.

2500000